Q2Earth’s Bioscience Subsidiary, QSAM Therapeutics, Signs License for Promising Drug to Treat Bone Cancer Palm Beach, FL, April 28, 2020 (GLOBE NEWSWIRE) -- Q2Earth, Inc. (OTCQB: QPWR) (the “Company” or “Q2”) announced today that its wholly-owned subsidiary, QSAM Therapeutics Inc. (“QSAM”), has signed...